Recombinant human Cdk7 + Cyclin H/p34 protein (Active)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant human Cdk7 + Cyclin H/p34 protein (Active) is a Human Full Length protein, in the 1 to 323 aa range, expressed in Baculovirus infected Sf9 cells, with >70%, suitable for SDS-PAGE, FuncS.
View Alternative Names
CAK, CAK1, CDKN7, MO15, STK1, CDK7, Cyclin-dependent kinase 7, 39 kDa protein kinase, CDK-activating kinase 1, Cell division protein kinase 7, Serine/threonine-protein kinase 1, TFIIH basal transcription factor complex kinase subunit, p39 Mo15
- FuncS
Supplier Data
Functional Studies - Recombinant human Cdk7 + Cyclin H/p34 protein (Active) (AB268398)
The specific activity of ab268398 was 3.0 nmol/min/min in a kinase assay using myelin basic protein as substrate.
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant human Cdk7 + Cyclin H/p34 protein (Active) (AB268398)
SDS-PAGE analysis of ab268398.
Reactivity data
Product details
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Cdk7-Cyclin H/p34 complex plays a significant role in cell cycle regulation acting at important checkpoints for transitioning between different phases of the cell cycle. It participates in the phosphorylation of other cyclin-dependent kinases therefore activating them and promoting cell cycle progression. The Cdk7-Cyclin H complex is an essential factor of the transcription process as it forms part of the transcription factor IIH (TFIIH) a multiprotein complex involved in transcription initiation and DNA repair.
Pathways
Cdk7 is an important regulator within the cell cycle and transcription regulation pathways. Notably it acts in close coordination with the p53 protein during DNA damage response ensuring genomic integrity through controlled cell cycle arrest. Additionally Cdk7 associates with the MAPK pathway linking signal transduction with cell cycle control which further exemplifies its broad regulatory impact within cells.
Specifications
Form
Liquid
Additional notes
Affinity purified.
General info
Function
Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts (PubMed : 9852112). Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.
Sequence similarities
Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.
Post-translational modifications
Phosphorylation of Ser-164 during mitosis inactivates the enzyme. Phosphorylation of Thr-170 is required for activity. Phosphorylated at Ser-164 and Thr-170 by CDK2.
Subcellular localisation
Nucleus
Target data
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com